Virtus ETF Advisers’s Enanta Pharmaceuticals ENTA Stock Holding History

Virtus ETF Advisers’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,784	Closed	-$143K	–	439
2023 Q3	$143K	Sell	12,784 -1,654	-11%	-$18.5K	0.09%	315
2023 Q2	$309K	Buy	14,438 +7,514	+109%	+$161K	0.18%	200
2023 Q1	$280K	Buy	6,924 +124	+2%	+$5.02K	0.15%	253
2022 Q4	$316K	Buy	6,800 +917	+16%	+$42.7K	0.17%	243
2022 Q3	$305K	Buy	5,883 +85	+1%	+$4.41K	0.12%	274
2022 Q2	$274K	Buy	5,798 +445	+8%	+$21K	0.1%	275
2022 Q1	$381K	Hold	5,353	–	–	0.17%	155
2021 Q4	$400K	Sell	5,353 -4,246	-44%	-$317K	0.15%	148
2021 Q3	$545K	Sell	9,599 -884	-8%	-$50.2K	0.24%	126
2021 Q2	$461K	Sell	10,483 -4,238	-29%	-$186K	0.19%	177
2021 Q1	$726K	Buy	14,721 +400	+3%	+$19.7K	0.31%	103
2020 Q4	$603K	Buy	14,321 +2,275	+19%	+$95.8K	0.25%	113
2020 Q3	$551K	Buy	12,046 +1,015	+9%	+$46.4K	0.29%	123
2020 Q2	$554K	Buy	11,031 +2,200	+25%	+$110K	0.26%	133
2020 Q1	$454K	Sell	8,831 -745	-8%	-$38.3K	0.19%	180
2019 Q4	$592K	Buy	9,576 +1,497	+19%	+$92.5K	0.1%	190
2019 Q3	$485K	Sell	8,079 -1,354	-14%	-$81.3K	0.1%	182
2019 Q2	$796K	Sell	9,433 -1,201	-11%	-$101K	0.17%	185
2019 Q1	$1.02M	Buy	10,634 +2,494	+31%	+$238K	2.16%	5
2018 Q4	$577K	Buy	8,140 +1,088	+15%	+$77.1K	0.1%	54
2018 Q3	$603K	Buy	7,052 +475	+7%	+$40.6K	0.06%	99
2018 Q2	$762K	Sell	6,577 -9,036	-58%	-$1.05M	0.67%	61
2018 Q1	$1.26M	Sell	15,613 -1,918	-11%	-$155K	1.1%	15
2017 Q4	$1.03M	Sell	17,531 -14,704	-46%	-$863K	1.29%	13
2017 Q3	$1.51M	Hold	32,235	–	–	0.2%	34
2017 Q2	$1.16M	Sell	32,235 -286	-0.9%	-$10.3K	0.17%	39
2017 Q1	$1M	Buy	32,521 +3,127	+11%	+$96.3K	0.18%	68
2016 Q4	$985K	Buy	29,394 +2,745	+10%	+$92K	0.29%	51
2016 Q3	$709K	Buy	26,649 +3,357	+14%	+$89.3K	0.34%	51
2016 Q2	$514K	Buy	23,292 +4,603	+25%	+$102K	0.38%	54
2016 Q1	$549K	Buy	+18,689	New	+$549K	0.76%	30